ImmunityBio Inc. Common Stock vs Roundhill NVDA WeeklyPay ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B), while Roundhill NVDA WeeklyPay ETF trades at $38 (market cap $119.10M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 88.2× Roundhill NVDA WeeklyPay ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Roundhill NVDA WeeklyPay ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Roundhill NVDA WeeklyPay ETF for 50 Days on average.
| IBRX | NVDW | |
|---|---|---|
Market Cap | $10.51B | $119.10M |
Volume | 10,445,785 | 44,838 |
Sector | Health | Income / Options Overlay |
52-Week High | $11.55 | $52.33 |
52-Week Low | $1.98 | $31.88 |
Typical Hold Time | 0 Days | 50 Days |
Enterprise Value | $10.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →